2024 annual financial data
Adaptive Biotechnologies 2024 Operating margin
Adaptive Biotechnologies 2024 operating margin with verified reported values.
Direct answer
Operating margin was -90.83%.
Operating income was -162,549,000 USD and net income was -159,492,000 USD.
Operating cash flow was -95,212,000 USD.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 178,957,000 USD
- Operating income
- -162,549,000 USD
- Net income
- -159,492,000 USD
- Operating cash flow
- -95,212,000 USD